Surveillance of gastrointestinal disease in France using drug sales data  by Pivette, Mathilde et al.
SM
a
b
c
d
e
V
a
A
R
R
A
A
K
P
D
D
E
G
I
f
r
e
2
2
P
1
i
u
(
b
d
c
i
m
R
h
1Epidemics 8 (2014) 1–8
Contents lists available at ScienceDirect
Epidemics
j ourna l ho me  pa ge: www.elsev ier .com/ locate /ep idemics
urveillance  of  gastrointestinal  disease  in  France  using  drug  sales  data
athilde  Pivettea,b,c,∗, Judith  E.  Muellera,d,  Pascal  Crépeya,e,  Avner  Bar-Henb
EHESP French School of Public Health, Sorbonne Paris Cité, Rennes, France
Université Paris Descartes, MAP5, Paris, France
Celtipharm, Vannes, France
Institut Pasteur, Emerging Diseases Epidemiology Unit, Paris, France
Aix Marseille Université, IRD French Institute of Research for Development, EHESP French School of Public Health, UMR  D 190 “Emergence des Pathologies
irales”, Marseille, France
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 18 December 2013
eceived in revised form 2 May  2014
ccepted 6 May 2014
vailable online 20 May  2014
a  b  s  t  r  a  c  t
Drug  sales  data  have  increasingly  been  used  for disease  surveillance  during  recent  years.  Our  objective  was
to  assess  the  value  of  drug  sales  data  as  an  operational  early  detection  tool  for gastroenteritis  epidemics
at  national  and  regional  level  in  France.  For  the  period  2008–2013,  we compared  temporal  trends  of  drug
sales  for  the  treatment  of  gastroenteritis  with  trends  of cases  reported  by  a Sentinel  Network  of  general
practitioners.  We  benchmarked  detection  models  to  select  the one  with  the  best  sensitivity,  false alerteywords:
opulation surveillance
isease outbreaks
rug utilization
pidemiology
astroenteritis
proportion  and  timeliness,  and  developed  a prospective  framework  to assess  the  operational  performance
of  the system.  Drug  sales  data  allowed  the  detection  of  seasonal  gastrointestinal  epidemics  occurring  in
winter  with  a distinction  between  prescribed  and  non-prescribed  drugs.  Sales  of  non-prescribed  drugs
allowed  epidemic  detection  on average  2.25  weeks  earlier  than  Sentinel  data.  These  results  conﬁrm  the
value of  drug  sales  data  for real-time  monitoring  of  gastroenteritis  epidemic  activity.
©  2014  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY-NC-SA
license  (http://creativecommons.org/licenses/by-nc-sa/3.0/).ntroduction
Drug sales data have increasingly been used in recent years
or outbreak detection and surveillance of acute diseases, like
espiratory (Das et al., 2005; Davies and Finch, 2003; Magruder
t al., 2004; Ohkusa et al., 2005; Vergu et al., 2006; Magruder,
003) or diarrheal diseases (Das et al., 2005; Edge et al., 2004,
006; Stirling et al., 2001; Proctor et al., 1998; Hogan et al., 2003;
elat et al., 2010; Kirian and Weintraub, 2010; Rodman et al.,
997). Although generally unspeciﬁc, drug sales data can provide
nformation within short delays, capture a large part of the pop-
lation and may  detect changes in the population health status
Henning, 2004).
Gastroenteritis is a highly infectious disease caused by viruses,
acteria and parasites. Symptoms are commonly vomiting and
iarrhea. Early detection of the start of gastroenteritis epidemics
ould limit their spreading, since preventative measures could be
mplemented and public health messages delivered in a timely
anner. Previous studies have shown that medications sales
∗ Corresponding author at: EHESP, Avenue du Professeur Léon Bernard, 35043
ennes, France. Tel.: +33 6 48412957.
E-mail address: mathilde.pivette@ehesp.fr (M.  Pivette).
ttp://dx.doi.org/10.1016/j.epidem.2014.05.001
755-4365/©  2014  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  undfor gastroenteritis are a good proxy of gastroenteritis incidence
(Edge et al., 2004, 2006; Stirling et al., 2001; Proctor et al.,
1998) and that outbreak onsets could be detected retrospectively
1.75 weeks–2.4 weeks before reference data (Hogan et al., 2003;
Pelat et al., 2010). The objective of the present study was  to
assess the value of drug sales data analysis as an operational
epidemic detection tool for gastroenteritis seasonal epidemics in
France. We  focused on gastroenteritis as it is a public health
issue for which early and valid detection is of particular interest
and because surveillance data of the disease, reported by a Sen-
tinel Network of physicians, are available in France (French GPs
Sentinelles Network). We  reﬁned analyses by using non-prescribed
and prescribed drug sales separately, as over-the-counter (OTC)
drugs have shown to be early indicators of diseases in previous
studies (Davies and Finch, 2003; Magruder et al., 2004; Vergu
et al., 2006; Magruder, 2003; Hogan et al., 2003; Najmi and
Magruder, 2005). We  ﬁrst retrospectively assessed the correlation
between medication sales and GP-reported cases of gastroenteri-
tis in France. We  performed a benchmark of detection models
to select the one with the best sensitivity, false alert propor-
tion and early detection, and we present a method which can
be used prospectively for detecting seasonal epidemics based on
weekly or daily drug sales data at both national and regional
scale.
er  the  CC  BY-NC-SA  license  (http://creativecommons.org/licenses/by-nc-sa/3.0/).
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ata sources
Daily drug sales data were extracted from a stratiﬁed sample of
ommunity pharmacies on the French metropolitan territory set up
y the company Celtipharm, Vannes, France (Celtipharm). The sam-
le size increased from 1086 pharmacies in 2008 to 3004 (13% of
he total pharmacies) in 2013. Real time sales data of these pharma-
ies are automatically and continuously collected, every day, since
007. Thanks to a constant up-to-date database of all the 22,458
rench active community pharmacies, Celtipharm built a stratiﬁca-
ionon sale revenue (6 levels for global revenue and 4 levels per type
f sales: prescribed drugs, OTC, and other type of sales), localisation
5 geographic areas) and sales area (5 types, from rural to densely
rban). Each stratum has a minimum of 30 pharmacies or is merged
ith neighbouring strata. Sampling rates per strata are computed
ith the Neyman optimal allocation algorithm (Kish, 1965). Extrap-
lations from this sample have been validated with data from drug
anufacturers who distribute their products to pharmacies. This
atabase has already been used in previous studies (Crépey et al.,
013a,b).
Reference surveillance data were obtained from the French
entinel Network of physicians (French GPs Sentinelles Network;
alleron et al., 1986; Flahault et al., 2006). The network is
onstituted of 1300 volunteer general practitioners working in
etropolitan France (2% of the total GPs). They transmit each week
ata from their patient consultations on 8 health indicators via
nternet connections. Cases of acute diarrhea are reported since
990. A case of acute diarrhea is deﬁned as a patient having at least
hree daily, soft or watery stools in the past 14 days. Weekly data are
xtrapolated to the national level and are accessible online (French
Ps Sentinelles Network). In France, surveillance of gastroenteritis
s also based on hospital emergency data and laboratory data in case
f investigation of localized outbreaks (school, nursing home. . .)
Invs French Institute for Public Health Surveillance). However, we
sed Sentinel Network data as reference because they are more
epresentative of the general population.
ndicator drugs selection
We  selected groups of products likely to be prescribed or bought
or gastroenteritis. Pharmaceutical products are aggregated into
lasses according to the Anatomical Classiﬁcation of the Euro-
ean Pharmaceutical Marketing Research Association (EPHMRA)
ased on their anatomical site of action, main indication, thera-
eutic use and composition. We  selected the following medication
lasses (class code): intestinal antiinfectives antidiarrheals (A07A),
ntestinal adsorbents antidiarrheals (A07B), antidiarrheal microor-
anisms (A07F), motility inhibitors (A07H), other antidiarrheals
A07X), other antiemetics and antinauseants (A04A9). Drugs for
otion sickness were excluded from the antiemetic group (A04A9).
e also selected two classes of parapharmaceutical products: oral
ehydration solutions and alimentary products for vomiting and
iarrhea commonly used for children. The total selection contains
 classes, corresponding to 256 products (Fig. S1).
ata
The study period lasted from January 7, 2008 (week 2 2008) to
une 30, 2013 (week 26 2013). We  used the weekly number of cases
er 100,000 inhabitants. For drugs, we used the weekly and daily
umber of boxes sold per 100,000 inhabitants at the national and
egional level. We  differentiated products prescribed by a health
ractitioner and products purchased without prescription.ics 8 (2014) 1–8
Correlation analysis
Cross-correlation analyses were performed to measure the sim-
ilarity of the time series at different time lags and the dates of
peak in each time series were compared. Since reference data were
obtained on a weekly basis, correlation analysis and peak compar-
isons were performed on weekly data.
Epidemics detection method
To identify epidemic periods in drug sales data series, we  applied
a Serﬂing-type periodic regression model, a widely-used method
for detecting outbreaks for diseases with a seasonal background
pattern (Costagliola et al., 1991). The method was  ﬁrst proposed
by Serﬂing (1963) and more recently implemented by Pelat et al.
(2007) in a software application. The drug data series are assumed
to be composed of a periodic baseline level and epidemic periods.
We  ﬁrst removed a highest N percentile of the observations (N is the
pruning value) in the training period (e.g. the highest 30%). A model
is then ﬁtted on the remaining data to estimate a non-epidemic
baseline level. We  modeled the baseline level with a linear trend
and commonly used periodicities of 12, 6 and 3 months. We  deﬁned
the threshold as the upper bound of the prediction interval (PI) of
the non-epidemic level (Pelat et al., 2007). An epidemic is deﬁned
when a deﬁned number of observations are above the threshold,
depending on the detection rule. The onset of an epidemic corre-
sponds to the ﬁrst observation above the threshold.
Primary and secondary analyses were performed using weeks
and days, respectively, as time unit. For daily analyses, we removed
Sundays and public holidays, as most pharmacies in France are
closed those days. We  also removed one day before and after public
holidays, as sales are higher than expected. We added a weekly peri-
odicity in the periodic regression model based on the sales of each
weekday to take into account the day-of-the-week effect (Table S1)
described in other studies (Ohkusa et al., 2005; Magruder, 2003).
The model equations are given in appendix (Text S1).
To identify the best detection model, we  tested different key
parameters. We  excluded between 15% and 40% of the highest
observations in the training period. Thresholds were deﬁned by
taking the upper limit of the 90%, 95% and 99% prediction interval.
We tested detection rules of 1 or 2 consecutive weeks above the
threshold to deﬁne an epidemic for weekly analyses, and detection
rules of 2–8 consecutive epidemic days for daily analyses.
Epidemics detection evaluation
The reference epidemic periods were the epidemic periods at
the national level as they had been deﬁned and published by the
Sentinel Network, using periodic regression models on acute diar-
rhea incidence rates (French GPs Sentinelles Network). We  deﬁned
a “detection window” of 4 weeks before and 4 weeks after the onset
of epidemics deﬁned by the Sentinel Network. The choice of a wide
detection window will enable the detection of very early signals of
epidemics, until 4 weeks before reference data.
A true positive alert was deﬁned as an epidemic onset computed
from drug data occurring in the detection window. A false positive
alert was deﬁned as an epidemic onset computed from drug data
occurring outside the detection window. The sensitivity represents
the proportion of seasonal epidemics that are detected by the drug-
based detection system, i.e. if at least one positive alert occurred
in the detection window. False alert proportion was deﬁned as
the ratio of false positive alerts to the total number of alerts. We
focused only on the start of the epidemics, regardless of their dura-
tion. Timeliness is deﬁned as the time difference between the ﬁrst
true positive alert and the start of epidemic period from Sentinel
Network. Timeliness is undeﬁned when no alert is emitted in the
M. Pivette et al. / Epidemics 8 (2014) 1–8 3
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pig. 1. Weekly sales of prescribed and non-prescribed drugs for gastroenteritis (in 
rom  a Sentinel Network of general practitioners (in number of cases for 100,000 in
etection window. Note that a true positive alert can occur at max-
mum 4 weeks before the detection from Sentinel Network, given
ur detection window. For daily data, timeliness was  calculated
sing as reference the ﬁrst day (Monday) of the ﬁrst epidemic week
rom Sentinel Network, as epidemic detection from Sentinel is only
ased on weekly data.
We  calculated sensitivity, false alert proportion and timeliness
or the different models by varying the key parameters (pruning
alue, PI and detection rule). The objective was to ﬁnd the set of
arameters allowing ﬁrst the highest sensitivity, then the lowest
alse alert proportion, and we ﬁnally kept, among that selection,
he parameters allowing the earliest detection.
eographical analyses
To evaluate the surveillance tool at regional level and to describe
eographical dynamics of gastroenteritis, we applied the selected
eriodic regression models on regional time series of drug sales
ata. In each region, every week was deﬁned as epidemic or non-
pidemic. We  constructed maps representing the weekly epidemic
tatus of the 21 administrative regions of metropolitan France (Cor-
ica excluded).
rospective detection during 2012/2013
To assess the real time performance of the detection model,
e evaluated the epidemic detection performance on the last year
2012–2013) based on weekly and daily non-prescribed drug sales,
fter ﬁtting a periodic regression model on the four preceding years
2008–2012). We  ﬁrst selected the best detection model for the
eriod 2008–2012, using the methodology previously described.
he selected model is then extrapolated to forecast an epidemic
hreshold for the following year (2012–2013). We evaluated sen-
itivity, false alert proportion and timeliness of the detection in
012–2013.
All analyses were performed on R Statistical software
www.r-project.org) and Microsoft Ofﬁce Excel 2010. Maps were
repared with the R statistical software.er of boxes sold for 100,000 inhabitants), and incidence of gastroenteritis obtained
nts). Metropolitan France, calendar week 2 of 2008 to week 26 in 2013.
Results
Descriptive analysis
The ﬁve main peaks in the data series of diarrhea incidence
rates were also observed in the sale rates of prescribed and non-
prescribed drugs (Fig. 1), and in each of the eight individual drug
classes (Fig. S2). All main peaks occurred during winter months.
Milder increases during summer months were also observed in
drug sales series, but not with diarrheal cases. This summer increase
appeared among all classes, being most pronounced for sales of oral
rehydration solutions and motility inhibitors. Weekly incidences
ranged from 66 to 577 cases per 100,000 inhabitants. Weekly drug
boxes sold for 100,000 inhabitants ranged from 310 to 1260 for
non-prescribed drugs and from 503 to 1829 for prescribed drugs.
Overall, the number of prescribed drug sales was 1.9 times higher
than the number of non-prescribed drug sales (in France, drugs
need to be prescribed to be reimbursed by the French Health insur-
ance).
The prescribed drug sales and the number of reported cases were
highly correlated, with a maximum correlation coefﬁcient of 0.89
at no time lag. The maximum correlation between non-prescribed
drug sales and cases was observed at a time lag of −1 week with a
coefﬁcient of 0.77.
During all ﬁve epidemic periods, the peak occurred ﬁrst in non-
prescription drug sales and on average 1.2 weeks before the peak
in Sentinel cases. Peaks in prescribed drug sales lagged behind Sen-
tinel data peaks by on average 0.7 weeks (Table 1).
Evaluation of epidemic detection performance
Non prescribed drug sales
Weekly data analyses. Analyzing weekly sales of non-prescription
drugs, the best detection performance was obtained in a model
with a pruning value of 30%, a PI of 99% and with an epidemic
period being deﬁned when at least two  weeks exceed the threshold
(Table 2). In this model, non-prescription drugs allowed detec-
ting all ﬁve seasonal epidemics, with no false alert and detection
occurred on average 1.6 weeks earlier (median: −2; min: −3; max:
4 M. Pivette et al. / Epidemics 8 (2014) 1–8
Table 1
Timing of winter peak for each time series and peak comparison between drug sales data and consultation-based sentinel data. Metropolitan France, week 2 of 2008 to week
26  of 2013.
Winter period Cases (calendar
week of peak)
Non prescribed drugs
(calendar week of
peak)
Time difference between the
peaks in non-prescribed drugs
and in Sentinel data (weeks)
Prescribed drugs
(calendar week
of peak)
Time difference between the
peaks in prescribed drugs and
in Sentinel data (weeks)
2008/2009 2009 02 2009 01 −1 2009 02 0
2009/2010 2010 02 2009 53 −2 2010 03 +1
2010/2011 2011 01 2010 52 −1 2011 01 0
2011/2012 2012 01 2011 52 −1 2012 03 +2
2012/2013 2013 01 2012 52 −1 2013 02 +1
Mean timeliness (weeks) −1.2 0.7
Table 2
Sensitivity, false alert proportion and timeliness in detection of gastroenteritis from weekly non-prescribed drug sales. Metropolitan France, week 2 of 2008 to week 26 of
2013.  The best detection model was obtained with a pruning value of 30%, and a prediction interval of 99% (gray shade).
PI (%) Pruning value (%) Sensitivity False alert proportion Mean timeliness (weeks) Median timeliness (weeks)
90 15 1 0.17 −1.6 −2
90  20 1 0.17 −2.0 −2
90  25 1 0.29 −2.2 −3
90  30 1 0.50 −2.4 −3
90  35 1 0.55 −2.4 −3
90  40 0.8 0.67 −2.0 −2
95  15 1 0.17 −1.2 −2
95  20 1 0.17 −1.6 −2
95  25 1 0.17 −2.0 −2
95  30 1 0.38 −2.2 −3
95  35 1 0.44 −2.4 −3
95  40 0.8 0.69 −2.0 −2
99  15 1 0 −1.0 −1
99  20 1 0 −1.2 −2
99  25 1 0 −1.4 −2
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1). Detection was earlier in the four last seasonal epidemics, with
 mean timeliness of 2.25 weeks (Table 3, Fig. 2A).
aily data analyses. Analyzing daily data, the best detection per-
ormance was obtained in a model with a pruning value of 25%,
 PI of 90% and with an epidemic period being deﬁned when at
east seven consecutive observations were higher than the thresh-
ld. The resulting sensitivity was of 100% with no false alert, and
he detection occurred on average 12.4 days earlier (median: −16;
in: −25; max: +5;). Detection occurred ﬁrst from non-prescribed
rugs in the four last epidemics with a mean timeliness of 16.75
ays (Table S2, Fig. S3).
rescribed drug sales
eekly data analyses. Analyzing weekly sales of prescribed drugs,
he best performing model used a pruning value of 30%, a PI of
5% a detection rule of two consecutive epidemic weeks (Table S3).
ensitivity was 100%, with no false alert, and a detection occurring
able 3
tart of epidemic periods obtained each winter from non-prescribed drugs (based on the 
based  on the selected model with a pruning value of 30% and a PI of 95%) and timelines
eek  26 of 2013.
Year Sentinel Network
epidemic period
(calendar week of start)
Non prescribed drugs
epidemic period
(calendar week of start)
Tim
fro
dru
Sen
2008/2009 2008 49 2008 50 +1
2009/2010 2009 53 2009 52 −1
2010/2011 2010 52 2010 50 −2
2011/2012 2012 01 2011 50 −3
2012/2013 2012 52 2012 49 −3
Mean timeliness −1
Median timeliness −2−1.6 −2
−2.2 −3
−2.4 −3
0.6 weeks earlier than reference data (median: 0; min: −2; max:
+1) (Fig. 2B, Table 3).
Daily data analyses. The best detection performance with daily data
was obtained for a pruning value of 40%, a PI of 95% and a detection
rule of six days. We  obtained a sensitivity of 80% with 20% of false
alert, and an average timeliness of +3.6 days (median: 1; min: 0;
max: 14). No parameters allowed 100% sensitivity without false
alert rate. The lower detection performance can be explained by
high inter-week variations in daily prescribed drug sales.
Prospective detection in 2012–2013
Using the best performing models ﬁtted only on the four preced-
ing years 2008–2012 (pruning value of 20% and PI 95% for weekly
data; pruning value of 20% and PI 90% for daily data), the epidemic
period in 2012–2013 was  detected without false alert. Based on
weekly and daily data, the epidemic period started, respectively, 3
selected model with a pruning value of 30% and a PI of 99%), from prescribed drugs
s of detection compared to Sentinel data. Metropolitan France, week 2 of 2008 to
eliness of detection
m non prescribed
gs compared to
tinel data (weeks)
Prescribed drugs
epidemic period
(calendar week of start)
Timeliness of detection
from prescribed drugs
compared to Sentinel
data (weeks)
 2008 47 −2
 2010 01 +1
 2010 52 0
 2012 01 0
 2012 50 −2
.6 -0.6
 0
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Fig. 2. Weekly sales of non-prescribed drugs (A) and prescribed drugs (B) with the corresponding epidemic periods deﬁned by the selected detection models. Epidemic
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reriods  deﬁned by the Sentinel Network are represented with gridded surfaces.
eeks and 19 days earlier than the period deﬁned in the Sentinel
etwork (Fig. 3). As 2 consecutive epidemic weeks and 7 consecu-
ive epidemic days were necessary to conﬁrm an epidemic, the start
f the seasonal epidemic could have been declared on December 13
sing daily data and on December 16 using weekly data, whereas
eclaration based on the Sentinel Network (French GPs Sentinelles
etwork) was done on January 7.
eographical analyses
In Fig. 4, we represented the regions affected by gastroen-
eritis epidemic every week for each winter period. During the
our winters 2009–2013, we observed that some regions were
etected as epidemic even before the national detection from
rug sales. For example, based on non-prescribed drug sales anal-
sis in 2011–2012 and 2012–2013, epidemic was  ﬁrst detected
n the northeast regions of France and one week before the
ational detection. We  did not use reference data at regional
evel to evaluate the detection performance. Indeed, the sample
f sentinel physicians is relatively low and heterogeneous, which
mplies too much variability at a regional level to use them as
eference.Discussion
Our study presents a method for real-time detection of gas-
troenteritis epidemics based on drug sales data. Our results
suggest that non-prescribed drug sales allow epidemic detec-
tion substantially earlier than consultation-based sentinel
data.
Over-the-counter (OTC) sales of anti-diarrheals, anti-nauseants
and rehydration products have proven to be good indicators of gas-
troenteritis illness in several previous studies (Edge et al., 2004,
2006; Stirling et al., 2001; Proctor et al., 1998; Hogan et al., 2003;
Rodman et al., 1997) but only two  studies have shown the poten-
tial of drug sales for early detection of gastroenteritis compared
to traditional surveillance data. In Hogan et al. (2003), detection
from OTC electrolytes sales occurred an average 2.4 weeks earlier
than detection from hospital diagnoses of respiratory and diar-
rheal pediatric diseases in the eighteen outbreaks studied. In Pelat
et al. (2010), four therapeutic classes correlating with diarrhea
incidence were selected and an algorithm based on the selected
classes allowed the detection of seasonal gastrointestinal epi-
demics in France with a sensitivity of 100%, a speciﬁcity of 95%
and a timeliness of 1.7 weeks before ofﬁcial alerts. However, this
study did not make any distinction between OTC and prescription
6 M. Pivette et al. / Epidemics 8 (2014) 1–8
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vig. 3. Prospective epidemic detection in 2012–2013 using daily non-prescribed d
ine  indicates the epidemic detection from drug sales data. The 2012–2013 epidemi
f  the references to color in this ﬁgure legend, the reader is referred to the web  ver
rugs and used only a retrospective analysis framework that
o not allow conclusion on usefulness in real-time surveil-
ance.
Contrary to published studies that focused on OTC drug sales
Das et al., 2005; Edge et al., 2004, 2006; Stirling et al., 2001;
roctor et al., 1998; Hogan et al., 2003; Kirian and Weintraub, 2010;
odman et al., 1997), which can be purchased with or without a
rescription, we analyzed products which were actually purchased
ithout a prescription. Our analysis therefore reﬂects more pre-
isely self-medication behavior of the population, which appears
o allow more timely detection of epidemics.
We  found that the correlation between non-prescribed drugs
nd cases was highest with a one week lag-time, indicating a
ifferent timing in patient behavior. Non-prescription drug sales
eaked earlier than the number of cases every year. Non-prescribed
rug sales analysis allowed detecting all seasonal epidemics with-
ut false alert and the detection was earlier than reference data
n four out of ﬁve epidemics with a mean timeliness of 2.25
eeks. Using day as time unit, the detection was on average 16.75
ays earlier. This result suggests that non-prescribed drug sales
ig. 4. Weekly epidemic regions deﬁned using non-prescribed (A) and prescribed drugs 
rom  drug sales analysis at the national level are framed by a blue line, the detection w
etropolitan France (Corsica excluded), 2008–2013 winter seasons. (For interpretation
ersion of this article.)les data. Metropolitan France, week 2 of 2008 to week 26 of 2013. The vertical red
detected nineteen days earlier than Sentinel Network detection. (For interpretation
f this article.)
have the potential to be a sensitive, speciﬁc and timely indicator
of seasonal gastroenteritis epidemics. It seems that patients buy
non-prescribed drugs during the early phase of illness when they
become symptomatic, before or instead consulting a physician. The
detection occurred later with non-prescribed drugs only during the
ﬁrst year (2008–2009) of the study period; however, the sample
of pharmacies was  smaller at the beginning of the study period
and may  partly explain the differences observed with the following
years.
By contrast, we found that prescribed drug sales provided rel-
atively little beneﬁts in terms of early detection compared to
Sentinel reference surveillance data (on average 0.6 weeks). We
found high correlations between prescribed drug sales and the
number of reported cases, indicating that both time-series peak
approximately at the same time. This result conﬁrmed the ade-
quacy between the two  data sources and is explained by the fact
that patients buy drugs just after seeing a physician. Prescribed drug
sales can therefore be used as a source of information to monitor
gastroenteritis disease and is a good indicator of medical consulta-
tions.
(B) are represented in black for each winter period. The detection weeks obtained
eeks from Sentinel Network data at the national level are framed by a red line.
 of the references to color in this ﬁgure legend, the reader is referred to the web
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Data sales in our database were obtained on a daily basis,
hereas a majority of surveillance studies were based on weekly
ata. For non-prescribed drugs, the dates of epidemic detection
id not differ between analysis of daily and weekly data. The main
dvantage of daily sales data analysis is the number of observations
bove the threshold necessary to declare an epidemic period. Con-
rary to weekly data for which two consecutive epidemic weeks are
eeded, only seven consecutive epidemic working days are neces-
ary for epidemic detection based on daily data. Epidemic periods
an therefore be declared earlier using daily data and public health
esponse can be delivered more rapidly.
In our data collection system, data were available for analysis
ne day after the day of sale. This near-real-time collection allowed
he use of prospective analyses to detect epidemics. Our prospec-
ive analysis of the 2012–2013 season showed that non-prescribed
rug sales data would have allowed the detection of the epidemic
tart three weeks or 19 days earlier than the GP based sentinel sys-
em, and the warning would have been sent 25 days earlier than
fﬁcial alerts. This conﬁrms the potential of non-prescribed drugs
or timely real-time detection and suggests that the method may
e used to detect seasonal epidemics in advance. This gain in time-
iness may  be of interest for the short term planning of healthcare
esources (hospital wards and staff management) and for timing
ore effectively public health campaigns aimed at limiting the
pread of the disease, but it may  be of an even greater interest
n case of emergence or re-emergence of speciﬁc pathogens (e.g.
. coli).
One limitation of our study is the selection of category of prod-
cts, which was based on their indications. These products do
ot all have the same speciﬁcity for gastroenteritis and may  have
thers indications. However, analysis of products categories is a
imple method that limits the impact of individual drugs changes
ue to marketing-induced behavior or others causes of variability
e.g. sales promotion, advertising, out-of-stock issues, Hogan and
agner, 2006). Besides, some drugs that may  be used in case of gas-
roenteritis, such as analgesics or antipyretics, were not included
s there were not speciﬁc enough of the disease. We  could also
ot differentiate drugs bought for stockpiling in prevention of the
easonal gastroenteritis from the one immediately used. However,
udden and massive stockpiling by the population is unlikely to
ccur without a triggering public event, which could then be taken
nto account in the analysis. It is also likely that a medication pur-
hase is more difﬁcult to trigger than a web search query, which
akes our analysis more robust than web queries based systems
Olson et al., 2013; Pelat et al., 2009). The observed seasonality can-
ot be due to bias on data collection. Indeed, control series, such
s hormonal contraceptives, presented a stable number of sales
uring the study period (data not shown). The use of medications
ay vary by demographic factors, including age and gender (Frosst
t al., 2006), and only a part of the population with acute gastroen-
eritis consults or buys medications. A telephone-based survey
Van Cauteren et al., 2012), conducted in France on 260 patients
eporting acute gastroenteritis, found that only 30.9% of the par-
icipants purchased prescription-based medications and that 8.9%
urchased OTC drugs. However, underestimation is also an issue
n other types of surveillance system, as the same study showed
hat only 33.4% of the patients consulted a physician. The size of
he source population is not precisely known. Therefore, analysis
f drug sales may  not be appropriate to accurately estimate the
ncidence of gastro-enteritis in a population but is still a relevant
ool to determine dynamics of the disease.
We  focused on the high-intensity national seasonal gastroen-
eritis epidemics for which reference clinical data were available
nd reliable. The detection windows of 4 weeks before and after
he epidemic onset from reference data did not allow the detection
f localized outbreaks occurring during other periods of the year.ics 8 (2014) 1–8 7
For example, we observed increases in drug data sales during sum-
mer  months; one hypothesis is that the increase reﬂects localized
gastroenteritis outbreaks in summer. They are of low-intensity,
localized in smaller geographical region, and not currently captured
by the national network of general practitioners. Considering the
large number of pharmacies in the sample (3004) even at a regional
level (around 200 on average), we  can assume that analyzing drug
sales can be a useful alternative way  to monitor epidemic spread
at a local level. Data sales are available at the pharmacy level, and
sales increase in a localized geographical area could therefore be
detected rapidly. However to validate this approach, ﬁeld investi-
gations have to be conducted and ﬁeld data are needed (laboratory
data, GP consultations data, telephone-based data in the study area)
to compare drug sales data to the number of cases.
We could not currently validate our regional analysis with ref-
erence data since the French GP-based sentinel network is too
heterogeneous to provide reliable local estimates on a weekly basis.
However, our regional analysis suggests that local epidemics could
be detected even earlier than the national one, which could be
another way  to further improve public health alerts.
Drug sales data present many advantages in term of public
health surveillance. Data can be obtained in almost real-time, which
allows rapid assessment of a situation. Efforts and cost to auto-
matically collect sales data are lower compared to other types of
surveillance system. Finally, data collection is exhaustive for each
pharmacy, enabling the monitoring of a large number of diseases
at the same time.
Conclusion
Drug sales data contains information necessary to detect gas-
trointestinal epidemics occurring in winter but a distinction
between prescribed and non-prescribed drugs should be made in
order to maximize the timeliness of the detection. Sales of non-
prescribed drugs allow epidemic detection on average 2.25 weeks
earlier than GP reported clinical data. Our analyses conﬁrmed that
drug sales data analysis is a valid and useful tool for gastroenteri-
tis real-time and spatial surveillance. Analysis of drug sales could
also be interesting for the surveillance of diseases for which clinical
surveillance does not exist, is costly, or poorly reported. Therefore,
future drug sales studies should be developed for other infectious
diseases.
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